Pharmaceutical - Inflammatory diseases, Sanofi

Filter

Popular Filters

Osiris regains worldwide rights to Prochymal and Chondrogen from Sanofi

30-09-2012

As a result of the termination of its collaboration with Genzyme, a subsidiary of French drug major Sanofi…

BiotechnologyChondrogenGenzymeImmunologicalsInflammatory diseasesLicensingOsiris TherapeuticsPharmaceuticalProchymalSanofi

Back to top